Articles by Joerg Zimmermann - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Joerg Zimmermann

Best Practices for Restricted Access Barrier Systems

RABS maximize product control but minimize operator interaction.
Sep 2, 2013

Restricted access barrier systems (RABS) maximize product control but minimize operator interaction in aseptic manufacturing.

Best Practices for Restricted Access Barrier Systems in Aseptic Manufacturing

RABS is a flexible barrier system that maximizes product control but minimizes operator interaction when best practices are followed.
Aug 21, 2013

RABS is a flexible barrier system that maximizes product control but minimizes operator interaction when best practices are followed.

Comparing Lyophilization in Vials and Dual-Chamber Systems

The author discusses the relative advantages and disadvantages of lyophilization in vials and dual-chamber systems.
Feb 15, 2012

The author discusses the relative advantages and disadvantages of lyophilization in vials and dual-chamber systems.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here